Cardiovascular biotech Portola Pharmaceuticals raises $70M, eyes IPO

May 9, 2007 | Matt Marshall | Comments | |

See David Hamilton’s story over at VentureBeat Life Sciences.

Next Story: Getting in to college
Previous Story: TheFunded capitulates, lets VCs post comments

Bookmark and Share

Photo of Matt Marshall

About the Author, Matt Marshall

Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.